Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 8 | 2023 | 883 | 1.610 |
Why?
|
| Drug Resistant Epilepsy | 4 | 2023 | 181 | 1.200 |
Why?
|
| Propylene Glycols | 1 | 2015 | 36 | 0.540 |
Why?
|
| Phenylcarbamates | 1 | 2015 | 25 | 0.530 |
Why?
|
| Ataxia | 2 | 2023 | 176 | 0.520 |
Why?
|
| Ocular Motility Disorders | 1 | 2015 | 47 | 0.520 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 69 | 0.510 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2015 | 134 | 0.500 |
Why?
|
| Intellectual Disability | 3 | 2022 | 1032 | 0.500 |
Why?
|
| Status Epilepticus | 1 | 2015 | 145 | 0.470 |
Why?
|
| Phosphotransferases (Phosphomutases) | 1 | 2012 | 3 | 0.450 |
Why?
|
| Disabled Children | 1 | 2012 | 26 | 0.430 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2012 | 37 | 0.420 |
Why?
|
| Microcephaly | 1 | 2015 | 325 | 0.420 |
Why?
|
| Homicide | 1 | 2012 | 36 | 0.420 |
Why?
|
| Epilepsy, Generalized | 2 | 2023 | 71 | 0.410 |
Why?
|
| Anticonvulsants | 1 | 2015 | 431 | 0.410 |
Why?
|
| Sleep Wake Disorders | 1 | 2015 | 348 | 0.410 |
Why?
|
| Tuberous Sclerosis | 2 | 2023 | 136 | 0.400 |
Why?
|
| Suicide | 1 | 2012 | 180 | 0.360 |
Why?
|
| Child Abuse | 1 | 2012 | 193 | 0.350 |
Why?
|
| Seizures | 7 | 2023 | 989 | 0.350 |
Why?
|
| Laser Therapy | 2 | 2023 | 411 | 0.330 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2022 | 413 | 0.300 |
Why?
|
| Genetic Testing | 1 | 2013 | 1589 | 0.250 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2023 | 13 | 0.240 |
Why?
|
| Myoclonus | 1 | 2023 | 34 | 0.230 |
Why?
|
| Hemispherectomy | 1 | 2023 | 25 | 0.230 |
Why?
|
| Electroencephalography | 3 | 2022 | 898 | 0.220 |
Why?
|
| Landau-Kleffner Syndrome | 1 | 2022 | 8 | 0.220 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2022 | 10 | 0.220 |
Why?
|
| Dystonic Disorders | 1 | 2023 | 81 | 0.210 |
Why?
|
| Dystonia | 1 | 2023 | 163 | 0.200 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 363 | 0.180 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2019 | 30 | 0.180 |
Why?
|
| Child | 9 | 2023 | 29154 | 0.170 |
Why?
|
| Brain Waves | 1 | 2019 | 50 | 0.170 |
Why?
|
| Child, Preschool | 7 | 2023 | 16273 | 0.150 |
Why?
|
| Child Development | 1 | 2019 | 255 | 0.150 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 621 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2023 | 32848 | 0.110 |
Why?
|
| Newspapers as Topic | 1 | 2012 | 7 | 0.110 |
Why?
|
| Child of Impaired Parents | 1 | 2012 | 17 | 0.110 |
Why?
|
| Eye Movements | 1 | 2012 | 116 | 0.110 |
Why?
|
| Gain of Function Mutation | 2 | 2023 | 126 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 545 | 0.100 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 96 | 0.100 |
Why?
|
| Suicide, Attempted | 1 | 2012 | 129 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2014 | 875 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 7702 | 0.090 |
Why?
|
| Humans | 14 | 2023 | 261506 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 1084 | 0.090 |
Why?
|
| Cause of Death | 1 | 2012 | 752 | 0.090 |
Why?
|
| Disease Progression | 1 | 2019 | 6682 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2014 | 1555 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 674 | 0.080 |
Why?
|
| Sex Factors | 1 | 2012 | 2139 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2023 | 37905 | 0.070 |
Why?
|
| Adolescent | 4 | 2023 | 31252 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2012 | 862 | 0.060 |
Why?
|
| Qb-SNARE Proteins | 1 | 2023 | 11 | 0.060 |
Why?
|
| 4-Aminopyridine | 1 | 2023 | 41 | 0.060 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2023 | 39 | 0.060 |
Why?
|
| Infant | 2 | 2023 | 13310 | 0.060 |
Why?
|
| Phenotype | 1 | 2014 | 6295 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 4314 | 0.050 |
Why?
|
| Male | 6 | 2023 | 123000 | 0.050 |
Why?
|
| Female | 7 | 2023 | 141928 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2022 | 79 | 0.050 |
Why?
|
| Incidence | 1 | 2012 | 5673 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2022 | 269 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 624 | 0.050 |
Why?
|
| Sleep | 1 | 2022 | 413 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2012 | 8223 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2022 | 641 | 0.040 |
Why?
|
| Chromosome Deletion | 1 | 2022 | 1005 | 0.040 |
Why?
|
| Aggression | 1 | 2019 | 252 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2022 | 998 | 0.030 |
Why?
|
| Risk Factors | 1 | 2012 | 17523 | 0.030 |
Why?
|
| United States | 1 | 2012 | 15433 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1945 | 0.030 |
Why?
|
| Facies | 1 | 2014 | 149 | 0.030 |
Why?
|
| Mutation | 2 | 2023 | 15179 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 77950 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2014 | 481 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 1471 | 0.020 |
Why?
|
| Middle Aged | 2 | 2014 | 86204 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 2232 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 5047 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 2265 | 0.020 |
Why?
|
| Young Adult | 1 | 2023 | 21445 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 4113 | 0.010 |
Why?
|